Dasatinib Monohydrate: Potent Tyrosine Kinase Inhibitor for Research and Therapeutic Applications
Explore the powerful inhibitory effects of this multi-targeted kinase inhibitor for your research needs.
Get a Quote & SampleProduct Core Value
Dasatinib Monohydrate
This advanced compound functions as a potent ATP-competitive inhibitor, offering broad-spectrum antiproliferative activity against various cancer cell lines. Its efficacy extends to overcoming resistance mechanisms in certain leukemias, making it a critical tool for researchers investigating kinase inhibition pathways.
- Investigate the impact of potent tyrosine kinase inhibitor activity on cellular pathways, leveraging comprehensive data on its Bcr-Abl inhibition.
- Utilize this key pharmaceutical intermediate in drug discovery pipelines, understanding its role in targeted cancer therapies.
- Advance your understanding of oncology drug development by exploring the applications of this crucial API for oncology.
- Source a reliable research chemical for Dasatinib studies, supporting critical cancer research and development efforts.
Key Advantages
Unmatched Potency
Demonstrates exceptional potency as an ATP-competitive inhibitor, crucial for precise cellular signaling research and understanding kinase inhibitor mechanisms.
Broad Spectrum Activity
Exhibits wide-ranging antiproliferative effects, making it invaluable for studies across hematological and solid tumor research areas, supporting oncology drug development.
Overcomes Resistance
Effectively inhibits imatinib-resistant Bcr-Abl mutations, providing critical insights for overcoming therapeutic resistance in targeted cancer therapies.
Key Applications
Oncology Research
Essential for understanding the molecular mechanisms behind cancer, particularly in the study of tyrosine kinase inhibition and its role in disease progression.
Leukemia Treatment Studies
A vital compound for research into chronic myeloid leukemia (CML) and acute lymphoblastic leukemia (ALL), offering insights into therapeutic strategies.
Tyrosine Kinase Inhibition
Enables in-depth investigation of the inhibition of various tyrosine kinases, supporting advancements in targeted therapy development.
Pharmaceutical API Development
Serves as a critical pharmaceutical intermediate and API for oncology, facilitating the development of new cancer treatments.